• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Up 0.13%

    More On OXGN

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Mateon Therapeutics, Inc. (OXGN)

    -NasdaqCM
    0.70 0.00(0.00%) Jun 17, 4:00PM EDT
    Prev Close:0.70
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:4.00
    Beta:2.02219
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.49 - 1.55
    Volume:0
    Avg Vol (3m):519,686
    Market Cap:18.66M
    P/E (ttm):N/A
    EPS (ttm):-0.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OXGN 0.00%18.66M
    AZNDown 0.54%83.62B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Mateon Therapeutics, Inc., a biopharmaceutical company, focuses on the development of vascular disrupting agents for the treatment of cancer in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback